Newest studies
Every summary in our library, newest first, as a dated timeline.
Showing 6,526–6,550 of 27,380 studies, newest first · page 262 of 1096.
May 2024 25
-
2024-05-31
Aducanumab: A look two years after its approval
43/100 ✓ Peer-reviewed Treatments Biomedica : revista del Instituto Nacional de Salud
Key finding: Alzheimer’s disease is the leading cause of dementia worldwide and a critical public health problem. +4 more findings
Full summary, score breakdown and related studies → Original source
-
2024-05-31
Incidence of Traumatic Brain Injury in a Longitudinal Cohort of Older Adults
57/100 ✓ Peer-reviewed Risk factors JAMA Network Open
Key finding: Among 9239 eligible respondents, 5258 (57.7%) were female and 1210 (9.1%) were Black, 574 (4.7%) were Hispanic, and 7297 (84.4%) were White. +4 more findings
Full summary, score breakdown and related studies → Original source
-
2024-05-31
[Blood biomarkers open a window to brain pathophysiology in Alzheimer's disease]
34/100 ✓ Peer-reviewed Tau biomarkers Lakartidningen
Key finding: Plasma levels of amyloid β, specifically the Aβ42/40 ratio, are reduced in Alzheimer's disease (AD) and show concordance with brain amyloidosis assessed by PET, but the overlap with normal elderly may be too large for reliable use in clinical applications. +3 more findings
Full summary, score breakdown and related studies → Original source
-
2024-05-30
Affiliate Stigma among family caregivers of individuals with dementia in China: a cross-sectional study
59/100 ✓ Peer-reviewed Caregiving Frontiers in public health
Key finding: The mean score for affiliate stigma of dementia family caregivers was 48.09 ± 16.38 (range: 22-86). +3 more findings
Full summary, score breakdown and related studies → Original source
-
2024-05-30
Causal association between particulate matter 2.5 and Alzheimer's disease: a Mendelian randomization study
43/100 ✓ Peer-reviewed Risk factors Frontiers in public health
Key finding: Our MR analysis identified a notable association between genetically predicted PM2.5 (PM with a diameter of 2.5 μm or less) exposure and an elevated risk of AD (odds ratio, 2.160; 95% confidence interval, 1.481 to 3.149; p < 0.001). +4 more findings
Full summary, score breakdown and related studies → Original source
-
2024-05-30
Integrating a multimodal lifestyle intervention with medical food in prodromal Alzheimer's disease: the MIND-ADmini randomized controlled trial
82/100 ✓ Peer-reviewed Prevention trials Alzheimer's research & therapy
Key finding: Primary outcome was feasibility of the multimodal intervention, evaluated by recruitment rate during a 6-month recruitment phase, overall adherence in each intervention arm, and 6-month retention rate. +4 more findings
Full summary, score breakdown and related studies → Original source
-
2024-05-30
Medicare Advantage enrollment and outcomes of post-acute nursing home care among patients with dementia
36/100 ✓ Peer-reviewed Health systems and care delivery Health Affairs Scholar
Key finding: After adjusting for patient-level characteristics and county fixed effects, we found that MA enrollment was not associated with days spent at home, nursing home days, likelihood of becoming a long-stay resident, hospital days, hospital readmission, or 1-year mortality. +3 more findings
Full summary, score breakdown and related studies → Original source
-
2024-05-29
Geographic Variation of Antidementia and Antipsychotic Medication Use Among US Nursing Home Residents With Dementia
49/100 ✓ Peer-reviewed Risk factors Medical Care
Key finding: memantine, cholinesterase inhibitor (ChEI), antipsychotic use] estimated adjusted odds ratios (aOR) and 95% CIs for resident, facility, and HRR characteristics. +4 more findings
Full summary, score breakdown and related studies → Original source
-
2024-05-29
A multimodal machine learning model for predicting dementia conversion in Alzheimer’s disease
53/100 ✓ Peer-reviewed Health systems and care delivery Scientific Reports
Key finding: As a result of testing the robustness of the model, the GBM model was the most stable, and in modality combination, model performance was further improved in the absence of T2-FLAIR image features.
Full summary, score breakdown and related studies → Original source
-
2024-05-29
Cholinesterase inhibitors and memantine are associated with a reduced mortality in nursing home residents with dementia: a longitudinal observational study
61/100 ✓ Peer-reviewed Treatments Alzheimer's Research & Therapy
Key finding: The use of conventional anti-dementia drugs is associated with a lower mortality in nursing home residents with dementia and should be widely used in this population. +3 more findings
Full summary, score breakdown and related studies → Original source
-
2024-05-28
Environmental pollution and extreme weather conditions: insights into the effect on mental health
43/100 ✓ Peer-reviewed Risk factors Frontiers in psychiatry
Key finding: However, the knowledge about possible psychiatric disorders associated with these exposures is currently not well disseminated. +3 more findings
Full summary, score breakdown and related studies → Original source
-
2024-05-28
Physical exercise, cognition, and brain health in aging
71/100 ✓ Peer-reviewed Prevention trials Trends in neurosciences
Key finding: We conclude by highlighting goals for future studies, including addressing unexplored neurobiological mechanisms and the inclusion of under-represented populations.
Full summary, score breakdown and related studies → Original source
-
2024-05-28
An immersive virtual reality shopping task detects declines in instrumental activities of daily living in individuals with Parkinson's disease
39/100 ✓ Peer-reviewed Risk factors Parkinsonism & Related Disorders
Key finding: There were no between-group differences in traditional performance measures of motor, cognitive, or IADL function. +4 more findings
Full summary, score breakdown and related studies → Original source
-
2024-05-26
The Association of Ancillary Diagnostic Tests With Outcome in Dementia
50/100 ✓ Peer-reviewed Health systems and care delivery Journal of the American Medical Directors Association
Key finding: Patients who underwent CSF testing or PET/SPECT had higher mean total health care costs as compared to controls (CSF €248, 95% CI 64-433; PET/SPECT: €315, 95% CI 179-451). +2 more findings
Full summary, score breakdown and related studies → Original source
-
2024-05-24
Biobank-wide association scan identifies risk factors for late-onset Alzheimer's disease and endophenotypes
63/100 ✓ Peer-reviewed Genetics eLife
Key finding: Compared to traditional approaches, BADGERS uses GWAS summary statistics as input and does not require multiple traits to be measured in the same cohort. +4 more findings
Full summary, score breakdown and related studies → Original source
-
2024-05-24
Neuronal glutathione depletion elevates the Aβ42/Aβ40 ratio and tau aggregation in Alzheimer's disease mice
43/100 ✓ Peer-reviewed Biomarkers FEBS letters
Key finding: These findings suggest that the decline in glutathione levels, due to aging or AD pathology, may contribute to the progression of AD.
Full summary, score breakdown and related studies → Original source
-
2024-05-24
A Data-Driven Approach to Defining Risk-Adjusted Coding Specificity Metrics for a Large U.S. Dementia Patient Cohort
43/100 ✓ Peer-reviewed Health systems and care delivery Healthcare (Basel, Switzerland)
Key finding: Inadequate coding specificity can have significant consequences at administrative and patient levels. +2 more findings
Full summary, score breakdown and related studies → Original source
-
2024-05-24
Alzheimer's disease and its treatment-yesterday, today, and tomorrow
51/100 ✓ Peer-reviewed Drug development Frontiers in pharmacology
Key finding: AD is a multi-factorial neurodegenerative disorder with familial, life style and comorbidity influences impacting a global population of more than 47 million with a projected escalation by 2050 to exceed 130 million. +3 more findings
Full summary, score breakdown and related studies → Original source
-
2024-05-23
A TrkB and TrkC partial agonist restores deficits in synaptic function and promotes activity-dependent synaptic and microglial transcriptomic changes in a late-stage Alzheimer's mouse model
46/100 ✓ Peer-reviewed Disease mechanisms Alzheimer's & dementia : the journal of the Alzheimer's Association
Key finding: In APPL/S mice, BD10-2 treatment improved memory and LTP deficits. +4 more findings
Full summary, score breakdown and related studies → Original source
-
2024-05-23
Hearing Loss and Cognitive Decline in the Aging Population: Emerging Perspectives in Audiology
43/100 ✓ Peer-reviewed Risk factors Audiology research
Key finding: Highlighting the evolving significance of audiologists in the dual management of cognitive health and hearing impairments, the author focuses on their role in identifying early signs of cognitive impairment and evaluates various cognitive screening tools used in this context. +4 more findings
Full summary, score breakdown and related studies → Original source
-
2024-05-23
Adult-onset hearing loss and incident cognitive impairment and dementia - A systematic review and meta-analysis of cohort studies
89/100 ✓ Peer-reviewed Risk factors Ageing research reviews
Key finding: We identified fifty studies (N=1,548,754). +4 more findings
Full summary, score breakdown and related studies → Original source
-
2024-05-23
Combining plasma Aβ and p-tau217 improves detection of brain amyloid in non-demented elderly
69/100 ✓ Peer-reviewed Biomarkers Alzheimer's research & therapy
Key finding: Aβ-PET was abnormal in 81 participants from J-TRC and 71 participants from BioFINDER. +1 more finding
Full summary, score breakdown and related studies → Original source
-
2024-05-23
Irisin Levels in Cerebrospinal Fluid Correlate with Biomarkers and Clinical Dementia Scores in Alzheimer Disease
51/100 ✓ Peer-reviewed Tau biomarkers Annals of neurology
Key finding: Irisin, released by muscles during exercise, was recently identified as a neuroprotective factor in mouse models of Alzheimer disease (AD). +3 more findings
Full summary, score breakdown and related studies → Original source
-
2024-05-23
Distinct roles of TREM2 in central nervous system cancers and peripheral cancers
48/100 ✓ Peer-reviewed TREM2 and immune genetics Cancer cell
Key finding: Whether myeloid cell-directed therapeutic targets identified in peripheral non-CNS cancers are applicable to GBM requires further study. +3 more findings
Full summary, score breakdown and related studies → Original source
-
2024-05-22
Drug repurposing for neurodegenerative diseases
43/100 ✓ Peer-reviewed Drug development Progress in molecular biology and translational science
Key finding: Neurodegenerative diseases (NDDs) are neuronal problems that include the brain and spinal cord and result in loss of sensory and motor dysfunction. +2 more findings
Full summary, score breakdown and related studies → Original source
Browse the library by subject, with the full score breakdown →